{"pmid":32405081,"pmcid":"PMC7218373","title":"Point-of-care (POC) lung ultrasound in intensive care during the COVID-19 pandemic.","text":["Point-of-care (POC) lung ultrasound in intensive care during the COVID-19 pandemic.","Coronavirus disease 2019 has spread to every inhabited continent in the world. So far, plain radiography and computed tomography have been the mainstay of imaging methods used. The present analytical paper on the role of point-of-care lung ultrasound in this pandemic examines its diagnostic accuracy, clinical utility, and physical practicality in the intensive care unit.","Clin Radiol","Kulkarni, S","Down, B","Jha, S","32405081"],"abstract":["Coronavirus disease 2019 has spread to every inhabited continent in the world. So far, plain radiography and computed tomography have been the mainstay of imaging methods used. The present analytical paper on the role of point-of-care lung ultrasound in this pandemic examines its diagnostic accuracy, clinical utility, and physical practicality in the intensive care unit."],"journal":"Clin Radiol","authors":["Kulkarni, S","Down, B","Jha, S"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405081","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.crad.2020.05.001","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666802845372907521,"score":9.490897,"similar":[{"pmid":32327383,"pmcid":"PMC7164867","title":"Point of care and intensive care lung ultrasound: A reference guide for practitioners during COVID-19.","text":["Point of care and intensive care lung ultrasound: A reference guide for practitioners during COVID-19.","OBJECTIVES: Current events with the recent COVID-19 outbreak are necessitating steep learning curves for the NHS workforce. Ultrasound, although not used in the diagnosis of COVID-19 may be utilised by practitioners at the point of care (POC) or on the intensive care units (ITUs) where rapid assessment of the lung condition may be required. The aim of this article was to review current literature surrounding the use of lung ultrasound in relation to COVID-19 and provide Sonographers with a quick and digestible reference guide for lung pathologies. KEY FINDINGS: Ultrasound is being used in Italy and China to help review lung condition during the COVID-19 outbreak however not strictly as a diagnostic tool as Computed Tomography (CT) of the chest and chest radiographs are currently gold standard. Ultrasound is highly sensitive in the detection of multiple lung pathologies which can be demonstrated in conjunction with COVID-19 however to date there are no specific, nor pathognomonic findings which relate to COVID-19 on ultrasound. CONCLUSION: Lung ultrasound is highly sensitive and can quickly and accurately review lung condition creating potential to assess for changes or resolution over time, especially in the ITU and POC setting. However it should not be used as a diagnostic tool for COVID-19 due to low specificity in relation to the virus. IMPLICATIONS FOR PRACTICE: The adoption of lung ultrasound to monitor lung condition during the COVID-19 outbreak may reduce the need for serial exposure to ionising radiation on the wards and in turn reduce the number of radiographers required to attend infected wards and bays, protecting both patients and the workforce.","Radiography (Lond)","Moore, S","Gardiner, E","32327383"],"abstract":["OBJECTIVES: Current events with the recent COVID-19 outbreak are necessitating steep learning curves for the NHS workforce. Ultrasound, although not used in the diagnosis of COVID-19 may be utilised by practitioners at the point of care (POC) or on the intensive care units (ITUs) where rapid assessment of the lung condition may be required. The aim of this article was to review current literature surrounding the use of lung ultrasound in relation to COVID-19 and provide Sonographers with a quick and digestible reference guide for lung pathologies. KEY FINDINGS: Ultrasound is being used in Italy and China to help review lung condition during the COVID-19 outbreak however not strictly as a diagnostic tool as Computed Tomography (CT) of the chest and chest radiographs are currently gold standard. Ultrasound is highly sensitive in the detection of multiple lung pathologies which can be demonstrated in conjunction with COVID-19 however to date there are no specific, nor pathognomonic findings which relate to COVID-19 on ultrasound. CONCLUSION: Lung ultrasound is highly sensitive and can quickly and accurately review lung condition creating potential to assess for changes or resolution over time, especially in the ITU and POC setting. However it should not be used as a diagnostic tool for COVID-19 due to low specificity in relation to the virus. IMPLICATIONS FOR PRACTICE: The adoption of lung ultrasound to monitor lung condition during the COVID-19 outbreak may reduce the need for serial exposure to ionising radiation on the wards and in turn reduce the number of radiographers required to attend infected wards and bays, protecting both patients and the workforce."],"journal":"Radiography (Lond)","authors":["Moore, S","Gardiner, E"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32327383","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.radi.2020.04.005","keywords":["covid-19","itu","intensive care","lung ultrasound","pocus","point of care ultrasound"],"locations":["Italy","China"],"countries":["Italy","China"],"countries_codes":["ITA|Italy","CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138494649499648,"score":140.90346},{"pmid":32275766,"title":"Point-of-care lung ultrasound in patients with COVID-19 - a narrative review.","text":["Point-of-care lung ultrasound in patients with COVID-19 - a narrative review.","Ultrasound imaging of the lung and associated tissues may play an important role in the management of patients with COVID-19-associated lung injury. Compared with other monitoring modalities, such as auscultation or radiographic imaging, we argue lung ultrasound has high diagnostic accuracy, is ergonomically favourable and has fewer infection control implications. By informing the initiation, escalation, titration and weaning of respiratory support, lung ultrasound can be integrated into COVID-19 care pathways for patients with respiratory failure. Given the unprecedented pressure on healthcare services currently, supporting and educating clinicians is a key enabler of the wider implementation of lung ultrasound. This narrative review provides a summary of evidence and clinical guidance for the use and interpretation of lung ultrasound for patients with moderate, severe and critical COVID-19-associated lung injury. Mechanisms by which the potential lung ultrasound workforce can be deployed are explored, including a pragmatic approach to training, governance, imaging, interpretation of images and implementation of lung ultrasound into routine clinical practice.","Anaesthesia","Smith, M J","Hayward, S A","Innes, S M","Miller, A S C","32275766"],"abstract":["Ultrasound imaging of the lung and associated tissues may play an important role in the management of patients with COVID-19-associated lung injury. Compared with other monitoring modalities, such as auscultation or radiographic imaging, we argue lung ultrasound has high diagnostic accuracy, is ergonomically favourable and has fewer infection control implications. By informing the initiation, escalation, titration and weaning of respiratory support, lung ultrasound can be integrated into COVID-19 care pathways for patients with respiratory failure. Given the unprecedented pressure on healthcare services currently, supporting and educating clinicians is a key enabler of the wider implementation of lung ultrasound. This narrative review provides a summary of evidence and clinical guidance for the use and interpretation of lung ultrasound for patients with moderate, severe and critical COVID-19-associated lung injury. Mechanisms by which the potential lung ultrasound workforce can be deployed are explored, including a pragmatic approach to training, governance, imaging, interpretation of images and implementation of lung ultrasound into routine clinical practice."],"journal":"Anaesthesia","authors":["Smith, M J","Hayward, S A","Innes, S M","Miller, A S C"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275766","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1111/anae.15082","keywords":["covid-19","lung ultrasound","point-of-care ultrasound","training","workforce"],"topics":["Prevention"],"weight":1,"_version_":1666138491723972609,"score":133.6332},{"pmid":32416318,"title":"Lung Ultrasound for Cardiologists in the Time of COVID-19.","text":["Lung Ultrasound for Cardiologists in the Time of COVID-19.","Lung ultrasound (LUS) is a point-of-care ultrasound (POCUS) technique used for its portability, widespread availability, and ability to provide real-time diagnostic information procedural guidance. LUS outperforms lung auscultation and chest X-ray, and is an alternative to chest computed tomography in select cases. Cardiologists may enhance their physical and echocardiographic examination with the addition of LUS. We present a practical guide to LUS, including device selection, scanning, findings, and interpretation. We outline a 3-point scanning protocol using 2D and M-mode imaging to evaluate the pleural line, pleural space, and parenchyma. We describe LUS findings and interpretation for common causes of respiratory failure. We provide guidance specific of COVID-19, which at the time of writing is responsible for a global pandemic. In this context, LUS emerges as a particularly useful tool for the diagnosis and management of patients with cardiopulmonary disease.","Can J Cardiol","Kiamanesh, Omid","Harper, Lea","Wiskar, Katie","Luksun, Warren","McDonald, Michael","Ross, Heather","Woo, Anna","Granton, John","32416318"],"abstract":["Lung ultrasound (LUS) is a point-of-care ultrasound (POCUS) technique used for its portability, widespread availability, and ability to provide real-time diagnostic information procedural guidance. LUS outperforms lung auscultation and chest X-ray, and is an alternative to chest computed tomography in select cases. Cardiologists may enhance their physical and echocardiographic examination with the addition of LUS. We present a practical guide to LUS, including device selection, scanning, findings, and interpretation. We outline a 3-point scanning protocol using 2D and M-mode imaging to evaluate the pleural line, pleural space, and parenchyma. We describe LUS findings and interpretation for common causes of respiratory failure. We provide guidance specific of COVID-19, which at the time of writing is responsible for a global pandemic. In this context, LUS emerges as a particularly useful tool for the diagnosis and management of patients with cardiopulmonary disease."],"journal":"Can J Cardiol","authors":["Kiamanesh, Omid","Harper, Lea","Wiskar, Katie","Luksun, Warren","McDonald, Michael","Ross, Heather","Woo, Anna","Granton, John"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32416318","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.cjca.2020.05.008","topics":["Diagnosis"],"weight":1,"_version_":1666994545948098563,"score":132.24268},{"pmid":32409431,"title":"Point-of-care ultrasound and COVID-19.","text":["Point-of-care ultrasound and COVID-19.","Point-of-care ultrasound has an important role in the management of patients with COVID-19 infection. Because the utility of each application varies by setting, individual institutions should consider how they can best use ultrasound within their specific environments. In general, procedural guidance and focused echocardiography are high yield. Lung ultrasound has the potential to aid the diagnosis and management of patients with COVID-19 infection. Lower extremity point-of-care ultrasound for deep vein thrombosis may help guide decision making regarding anticoagulation or undifferentiated shock. It is of the utmost priority that ultrasound not spread infection, so point-of-care ultrasound must be used only when clinically indicated. Institutions should have protocols for machine disinfection.","Cleve Clin J Med","Fox, Steven","Dugar, Siddharth","32409431"],"abstract":["Point-of-care ultrasound has an important role in the management of patients with COVID-19 infection. Because the utility of each application varies by setting, individual institutions should consider how they can best use ultrasound within their specific environments. In general, procedural guidance and focused echocardiography are high yield. Lung ultrasound has the potential to aid the diagnosis and management of patients with COVID-19 infection. Lower extremity point-of-care ultrasound for deep vein thrombosis may help guide decision making regarding anticoagulation or undifferentiated shock. It is of the utmost priority that ultrasound not spread infection, so point-of-care ultrasound must be used only when clinically indicated. Institutions should have protocols for machine disinfection."],"journal":"Cleve Clin J Med","authors":["Fox, Steven","Dugar, Siddharth"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32409431","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3949/ccjm.87a.ccc019","topics":["Diagnosis"],"weight":1,"_version_":1666897319157563392,"score":130.57115},{"pmid":32500849,"title":"Frequency of Abnormalities Detected by Point-of-Care Lung Ultrasound in Symptomatic COVID-19 Patients: Systematic Review and Meta-Analysis.","text":["Frequency of Abnormalities Detected by Point-of-Care Lung Ultrasound in Symptomatic COVID-19 Patients: Systematic Review and Meta-Analysis.","The COVID-19 pandemic has resulted in significant morbidity, mortality, and strained healthcare systems worldwide. Thus, a search for modalities that can expedite and improve the diagnosis and management of this entity is underway. Recent data suggested the utility of lung ultrasound (LUS) in the diagnosis of COVID-19 by detecting an interstitial pattern (B-pattern). Hence, we aimed to pool the proportion of various reported lung abnormalities detected by LUS in symptomatic COVID-19 patients. We conducted a systematic review (PubMed, MEDLINE, and EMBASE until April 25, 2020) and a proportion meta-analysis. We included seven studies examining the role of LUS in 122 COVID-19 patients. The pooled proportion (PP) of B-pattern detected by lung ultrasound (US) was 0.97 (95% CI: 0.94-1.00 I (2) 0%, Q 4.6). The PP of finding pleural line abnormalities was 0.70 (95% CI: 0.13-1.00 I (2) 96%, Q 103.9), of pleural thickening was 0.54 (95% 0.11-0.95 I (2) 93%, Q 61.1), of subpleural or pulmonary consolidation was 0.39 (95% CI: 0.21-0.58 I (2) 72%, Q 17.8), and of pleural effusion was 0.14 (95% CI: 0.00-0.37 I (2) 93%, Q 27.3). Our meta-analysis revealed that almost all SARS-CoV-2-infected patients have abnormal lung US. The most common abnormality is interstitial involvement depicted as B-pattern. The finding from our review highlights the potential role of this modality in the triage, diagnosis, and follow-up of COVID-19 patients. A sizable diagnostic accuracy study comparing LUS, computed tomography scan, and COVID-19-specific tests is warranted to further test this finding and to delineate the diagnostic and prognostic yield of each of these modalities.","Am J Trop Med Hyg","Mohamed, Mouhand F H","Al-Shokri, Shaikha","Yousaf, Zohaib","Danjuma, Mohammed","Parambil, Jessiya","Mohamed, Samreen","Mubasher, Mahmood","Dauleh, Mujahed M","Hasanain, Bara","AlKahlout, Mohamed Awni","Abubeker, Ibrahim Y","32500849"],"abstract":["The COVID-19 pandemic has resulted in significant morbidity, mortality, and strained healthcare systems worldwide. Thus, a search for modalities that can expedite and improve the diagnosis and management of this entity is underway. Recent data suggested the utility of lung ultrasound (LUS) in the diagnosis of COVID-19 by detecting an interstitial pattern (B-pattern). Hence, we aimed to pool the proportion of various reported lung abnormalities detected by LUS in symptomatic COVID-19 patients. We conducted a systematic review (PubMed, MEDLINE, and EMBASE until April 25, 2020) and a proportion meta-analysis. We included seven studies examining the role of LUS in 122 COVID-19 patients. The pooled proportion (PP) of B-pattern detected by lung ultrasound (US) was 0.97 (95% CI: 0.94-1.00 I (2) 0%, Q 4.6). The PP of finding pleural line abnormalities was 0.70 (95% CI: 0.13-1.00 I (2) 96%, Q 103.9), of pleural thickening was 0.54 (95% 0.11-0.95 I (2) 93%, Q 61.1), of subpleural or pulmonary consolidation was 0.39 (95% CI: 0.21-0.58 I (2) 72%, Q 17.8), and of pleural effusion was 0.14 (95% CI: 0.00-0.37 I (2) 93%, Q 27.3). Our meta-analysis revealed that almost all SARS-CoV-2-infected patients have abnormal lung US. The most common abnormality is interstitial involvement depicted as B-pattern. The finding from our review highlights the potential role of this modality in the triage, diagnosis, and follow-up of COVID-19 patients. A sizable diagnostic accuracy study comparing LUS, computed tomography scan, and COVID-19-specific tests is warranted to further test this finding and to delineate the diagnostic and prognostic yield of each of these modalities."],"journal":"Am J Trop Med Hyg","authors":["Mohamed, Mouhand F H","Al-Shokri, Shaikha","Yousaf, Zohaib","Danjuma, Mohammed","Parambil, Jessiya","Mohamed, Samreen","Mubasher, Mahmood","Dauleh, Mujahed M","Hasanain, Bara","AlKahlout, Mohamed Awni","Abubeker, Ibrahim Y"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32500849","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.4269/ajtmh.20-0371","locations":["US","US","Symptomatic"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Diagnosis"],"weight":1,"_version_":1668804508693561345,"score":123.04738}]}